Orthopediatrics Corp Up 9.15% To $29.41 After Earnings Beat

Orthopediatrics Corp (KIDS) reported better than expected earnings this afternoon for Q4 2023.

Orthopediatrics Corp's earnings came in at an EPS loss of $0.23 per share, 18.00% higher than estimates for an EPS loss of $0.28 per share. The firm's loss per share narrowed by 28% since reporting a loss of $0.32 per share a year ago. Remember, earnings reported were on an adjusted basis, so they may not be comparable to prior reports and/or analyst estimates.

Revenues were downbeat at $37.6 million. That is an increase of 21.36% in revenues from the year-ago report and is 0.31% lower than consensus estimates set at $37.7 million.

The stock is up 9.15% to $29.41 after the report.

The firm's lower revenue growth to earnings signals that the firm has been able to reduce costs and improve its profit margin overall.

The average recommendation from Wall Street analysts was a Strong Buy which may get revised based on this new data.

InvestorsObserver gives the stock a Bearish Sentiment score at the moment based on recent trading.

Prior to the report, InvestorsObserver gave the stock an overall score of 32. Meanwhile, the average Wall Street analyst rated the stock a Strong Buy.

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.